What have studies shown regarding the benefits of using medications to treat toxic epidermal necrolysis (TEN)?

Updated: Jul 01, 2021
  • Author: Samantha P Jellinek-Cohen, PharmD, BCPS (AQ-ID); Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Multiple studies of these modalities have been completed, and multiple studies are ongoing. Completed studies have shown that either the risk of the medication outweighs the benefit or the data are inconclusive to support its utilization. Therefore, there is a significant need for randomized control studies to further evaluate potential treatment modalities in TEN.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!